Alterity Therapeutics (ATHE) Current Assets (2009 - 2025)

Alterity Therapeutics' Current Assets history runs 16 years deep, the most recent figure standing at $37.3 million for Q4 2025.

• In Q4 2025, Current Assets rose 446.92% year-over-year to $37.3 million; the TTM figure through Dec 2025 stood at $37.3 million (up 446.92% YoY), while the FY2025 annual figure was $29.4 million, up 134.16% from the prior year.
• Current Assets was $37.3 million for Q4 2025 at Alterity Therapeutics, up from $29.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $37.3 million in Q4 2025 to a low of $6.8 million in Q4 2024.
• Historically, Current Assets has averaged $22.8 million across 5 years, with a median of $23.8 million in 2021.
• The sharpest annual moves came in 2024 and 2025: Current Assets plunged 52.35% in 2024, then soared 446.92% in 2025.
• A 5-year view of Current Assets shows it stood at $32.7 million in 2021, then tumbled by 33.24% to $21.8 million in 2022, then sank by 34.38% to $14.3 million in 2023, then slumped by 52.35% to $6.8 million in 2024, then jumped by 446.92% to $37.3 million in 2025.
• The last three Current Assets figures came in at $37.3 million (Q4 2025), $29.4 million (Q2 2025), and $6.8 million (Q4 2024), per Business Quant data.